The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Reflux esophagitis is one of highly prevalent comorbidities among patients with chronic obstructive pulmonary disease

  • Jung, Ki-Suck (Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital)
  • Received : 2014.06.05
  • Accepted : 2014.06.12
  • Published : 2014.07.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Martinez CH, Mannino DM, Divo MJ. Defining COPD-related comorbidities, 2004-2014. J COPD Found 2014;1:51-63. https://doi.org/10.15326/jcopdf.1.1.2014.0119
  2. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:155-161. https://doi.org/10.1164/rccm.201201-0034OC
  3. Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 2013;107:1376-1384. https://doi.org/10.1016/j.rmed.2013.05.001
  4. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-735. https://doi.org/10.1164/rccm.201209-1665OC
  5. Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med 2013;13:51. https://doi.org/10.1186/1471-2466-13-51
  6. Putcha N, Han MK, Martinez CH, et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. J COPD Found 2014;1:105-114. https://doi.org/10.15326/jcopdf.1.1.2014.0112
  7. Sasaki T, Nakayama K, Yasuda H, et al. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc 2009;57:1453-1457. https://doi.org/10.1111/j.1532-5415.2009.02349.x
  8. Kim SW, Lee JH, Sim YS, Ryu YJ, Chang JH. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease. Korean J Intern Med 2014;29:466-473. https://doi.org/10.3904/kjim.2014.29.4.466
  9. Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 2011;140:626-633. https://doi.org/10.1378/chest.10-2948
  10. Balsamo R, Lanata L, Egan CG. Mucoactive drugs. Eur Respir Rev 2010;19:127-133. https://doi.org/10.1183/09059180.00003510
  11. Noth I, Zangan SM, Soares RV, et al. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J 2012;39:344-351. https://doi.org/10.1183/09031936.00099910